4/A
Changes in Ownership
ENDRA Life Sciences Inc. Filed Acc 0001209191-17-042113
Options or other derivatives
- Chief Technology Officer acquired 31,960 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Thornton Michael Milos · Chief Technology Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-06-09 | Grant or award : show line 1 in the form Stock Options | +31,960 | 31,960 | D |
Loading xslF345X03/doc4a.xml…